SUTIMLIMAB-JOME vs TACROLIMUS: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SUTIMLIMAB-JOME vs TACROLIMUS: Safety Overview
| Metric | SUTIMLIMAB-JOME | TACROLIMUS |
|---|---|---|
| Total FAERS Reports | 209 | 91,009 |
| Deaths Reported | 28 | 14,642 |
| Death Rate | 13.4% | 16.1% |
| Hospitalizations | 37 | 36,664 |
| Average Patient Age | 72.1 yrs | 46.7 yrs |
| % Female Patients | 69.9% | 44.1% |
| FDA Approval Date | N/A | Apr 16, 2018 |
| Manufacturer | N/A | Strides Pharma Science Limited |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |